Skip to main content
Clinical Trials/NCT04461847
NCT04461847UnknownNot Applicable

A Randomized Controlled Trial of Endoscopic Subcutaneous Mastectomy Versus Open Mastectomy in Early Breast Cancer Patients

Beijing Friendship Hospital1 site in 1 country287 target enrollmentStarted: December 1, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
287
Locations
1
Primary Endpoint
local recurrence rate

Study Overview

Brief Summary

The consideration of quality of life issues has led to the development of alternative surgeries for breast cancer patients, particularly in the case of localized disease. Nipple-sparing subcutaneous mastectomy (SM), for example, was designed to preserve the nipple-areola complex which facilitates breast reconstruction. However, SM still leaves behind a conspicuous scar.There have already been some observation study show that endoscopic subcutaneous mastectomy(ESM) can improve the cosmesis outcomes and at the same time as safe as the traditional SM.However there is no RCT in this field.That is why the investigators design this study.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Diagnosis of stages I or II ductal carcinoma
  • The distance from the tumor to the edge of the papilla is more than 3cm, the tumor volume is less than 3cm, the axillary lymph nodes have no obvious fusion and no adhesion with the axillary vein and brachial plexus
  • Age from 18~70
  • ECOG scores 0~2
  • Normal function of liver, kidney and bone marrow

Exclusion Criteria

  • Through physical examination and MRI, it was confirmed that the tumor did not invade the skin, but was confined to the gland and did not invade the surface of the gland.
  • There are serious medical diseases
  • Pregnant or lactating women women of childbearing age -

Outcomes

Primary Outcomes

local recurrence rate

Time Frame: 12 months after operation

Definition and diagnostic criteria of local recurrence: physical examination or imaging examination found lesions in the same side of breast, chest wall or skin and surgical scars, and confirmed by histology as breast cancer of the same tissue type; 12 months after operation, the evaluation was carried out.

Secondary Outcomes

  • Distant metastasis(12 months after operation)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Zhongtao Zhang

Director of general surgery, principal investigator

Beijing Friendship Hospital

Study Sites (1)

Loading locations...

Similar Trials